FDA Approval of PARP Inhibitors and the Impact on Genetic Counseling and Genetic Testing Practices.
J Genet Couns
; 27(1): 131-139, 2018 02.
Article
in En
| MEDLINE
| ID: mdl-28780754
Key words
Full text:
1
Database:
MEDLINE
Main subject:
Ovarian Neoplasms
/
Attitude of Health Personnel
/
Genetic Testing
/
Poly(ADP-ribose) Polymerase Inhibitors
/
Genetic Counseling
Type of study:
Prognostic_studies
Limits:
Female
/
Humans
Language:
En
Journal:
J Genet Couns
Journal subject:
GENETICA MEDICA
Year:
2018
Type:
Article
Affiliation country:
United States